Zoom link will be provided.

Panel including physicians, professors, and Yale students who have bridged the gap between biomedical engineering and real-world, clinical problems.

FREE Grubhub giftcards available for Yale-affiliated attendees. **You must register on Eventbrite and attend event to receive your ecard. Your code will be sent by email immediately following the event.

Panel speakers:

Dr. Stuart Campbell, PhD: Associate Professor of Biomedical Engineering & Cellular and Molecular Physiology

Dr. Stuart Campbell is an associate professor of biomedical engineering at Yale University, where he leads the Integrative Cardiac Biomechanics Laboratory. His research interests center on cardiac muscle physiology and mechanobiology in health and disease, with a special focus on inherited cardiac disorders known as cardiomyopathies. Using a combination of computational methods and in vitro disease models (primarily engineered heart tissue), his group is seeking to improve diagnosis and treatment for heart disease. In 2018, Dr. Campbell co-founded Propria LLC, a biotech startup that has licensed engineered heart tissue technology from his lab at Yale for further commercial development.

Mrinal Kumar: Yale BME ’18, Senior Consultant at ClearView Healthcare Partners Founder of OnTrack Rehab (outgrowth of MENG/BENG404); StartUp Yale Winner | Rothberg Prize

OnTrack Rehab is a multi-platform system that digitizes, streamlines, and optimizes modern oculo-vestibular rehabilitation practices. OnTrack uses a balance board to collect patient stability data and a virtual reality headset to collect information on patient head and eye movements. Through a series of VR games, OnTrack not only stimulates a patient’s eyes and balance to drive faster recovery but also quantifies their progress to ensure that they are healthy before they are medically cleared. Patient data are synthesized and securely stored on a cloud platform with user-friendly dashboards so that patients and physicians can track progress. These data can be analyzed and used to develop a standardized rehabilitation protocol for faster, safer patient recovery.

Lisa Lattanza, MD: Chair & Chief, Orthopaedics & Rehabilitation

Dr. Lisa Lattanza is a world- renowned leader in patient-specific 3D surgical planning and technology for deformity correction. She utilized her expertise in this area when she led a team to perform the first elbow-to-elbow transplant in the world in 2016, transplanting a patient’s left elbow into his right arm to give him one functioning extremity after a devastating accident. Using 3D computing, she also pioneered a new classification system and approach to the treatment of Chronic Monteggia Fracture Dislocations in children.

In 2009, she co-founded the Perry Outreach Program to increase exposure of high school girls to orthopaedic surgery and biomechanical engineering.

Dr. Lattanza is also part of the Coalition for Health Innovation in Medical Emergencies (CHIME), which seeks to bring together experts at Yale to improve the availability of essential personal protective equipment (PPE) for healthcare workers during the COVID-19 crisis.

David Pearlstone, MD MBA: Clinical surgical oncology; DICOM Director CEO

DICOM Director is the next generation of medical imaging, offering an augmented reality system for viewing MRIs and CT scans in 3D. This dramatically improves visualization of complex anatomic relationships, allowing a new level of pre-operative planning, intra-operative image guidance and post-operative case review.

Dr. David Pearlstone has over 20 years of experience in clinical surgical oncology. He has served on the faculty of the University of Medicine and Dentistry of New Jersey, as well as Yale University School of Medicine. In 2010, Dr. Pearlstone received his MBA from the Leadership in Healthcare program at the Yale University School of Management. Before joining DICOM Director, Dr. Pearlstone worked as the Executive Director of HealthHavenHub, a not-for-profit digital healthcare incubator in New Haven, CT, and a partner at HealthVenture, LLC.